About Helen F. Graham Cancer Center & Research Institute

With a cancer diagnosis, you need the right team. You’ll find it here.

Tour of Center Multidisciplinary Approach Technology Clinical Trials Research Contact Us

Most Advanced Cancer Center in The Country

If you or a loved one is facing a cancer diagnosis, the Helen F. Graham Cancer Center & Research Institute offers strength on all fronts: life-saving treatment options, multidisciplinary team care, cutting-edge research and ongoing support during and after treatment.

The Graham Cancer Center is one of the most advanced cancer centers in the country — with 248,000 annual patient visits and counting — making it a top choice for people in Delaware and surrounding states.

This content is hosted by a third party (YouTube). By showing the external content you accept YouTube's terms and conditions.

Show

Our Multidisciplinary Team Approach: Working Together, For You

With a cancer diagnosis, you need the right team. You’ll find it here.

The 240,000 square-foot Graham Cancer Center is a multidisciplinary cancer center, or MDC, which means an entire team of our highly skilled specialists work together to create and implement a treatment plan as unique as you. You’ll have a fully dedicated team that may include oncologists, surgeons, nurse navigators, social workers, and clinical research nurses to help connect you to cutting-edge treatments and the latest clinical trials.

Multidisciplinary care also means convenient, efficient care. You can see three disciplines of surgical, medical and radiation oncology, including subspecialists and support service teams, in a single visit. Explore the types of cancer we treat.

Leading Technology

Inside our doors, you’ll find the most advanced cancer technology in the region for detection, treatment and recovery. We offer:

The region’s only dedicated breast MRI scanner, a useful screening tool for women who have a high risk of breast cancer or dense breast tissue, as well as Fast Breast MRI, which may be used in conjunction with traditional mammography.
Low-dose CT scans, which help doctors detect lung cancer early.
The latest surgical tools for removing cancer with pinpoint accuracy, including CyberKnife Robotic Radiosurgery System and da Vinci Robotic Surgery System.
Minimally invasive video-assisted thoracoscopic surgery.
Breast reconstruction flap procedures, which use the body’s own tissue to create natural looking and feeling breasts following partial or full mastectomies.

Clinical Trials: Cancer Research That Benefits You

ChristianaCare’s cancer clinical trials program actively pursues today’s most promising studies for the prevention and treatment of cancer. When you join a cancer research study, you benefit from techniques and therapeutic advances that are at the vanguard of medical science. At the same time, you are helping to improve our knowledge in ways that will help people with cancer live longer and enjoy a better quality of life.

The Helen F. Graham Cancer Center & Research Institute enrolls seven times more patients in National Cancer Institute clinical trials than the national rate. We have received several national awards for our record-breaking success in enrolling patients in clinical trials. At any given time, we have at least 700 patients enrolled in as many as 130 different clinical trials. For our patients, this success means that they have access to the best treatments and procedures available to fight their type of cancer.

Pushing Boundaries With Research

“Research Institute” is an important part of our name, because we have taken a leading role in the region — and the nation — in cancer research. Following is a list of some of the research programs we are involved in:

Through our membership in the prestigious National Cancer Institute Community Oncology Research Program (NCORP), the Graham Cancer Center offers leading-edge NCORP clinical trials to the patients we are privileged to serve. The Graham Cancer Center also offers a robust pharmaceutical clinical trials program.
In 2009, we partnered with University of Delaware, Delaware Biotechnology Institute and others to expand wet labs and establish the Cawley Center for Translational Cancer Research (CTCR). This collaboration brings medical researchers and doctors together to bring scientific discoveries from the lab directly to the bedside of patients, with investigations of breast cancer, colon cancer, radiation oncology and tissue engineering. As one of only two non-university-based tissue-banking programs in the U.S., the Institute collects human tissue samples to advance understanding of cancer and fuel translational research that bridges basic science and potential therapies.
The Graham Cancer Center conducts industry-leading genetic engineering cancer research at the Gene Editing Institute. Discoveries here could well change the course of cancer treatment in the future.
Collaborations with world-renowned scientists at The Wistar Cancer Institute in Philadelphia are opening new avenues to more quickly translate cancer science into cancer medicine.